482
Participants
Start Date
May 18, 2020
Primary Completion Date
March 30, 2026
Study Completion Date
March 30, 2026
Beijing Chao-yang Hospital,Capital Medical University, Beijing
Peking University First Hospital, Beijing
Beijing Jishuitan Hospital, Beijing
Beijing Chao-yang Hospital,Capital Medical University(Shijingshan), Beijing
Peking University Third Hospital, Beijing
Peking Union Medical College Hospital, Beijing
The First Hospital of China Medical University, Shenyang
The First Affiliated Hospital of Dalian Medical University, Dalian
The First Bethune Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Zhabei Central Hospital, Jing'an District, Shanghai, Shanghai
Wuxi People's Hospital, Wuxi
The First Affiliated Hospital of Soochow University, Suzhou
Soochow Hongci Blood Disease Hospital, Suzhou
Anhui Cancer Hospital, Hefei
Tai'an Central Hospital, Tai’an
Affiliated Hospital of Jining Medical College, Jining
Tianjin Medical University General Hospital, Tianjin
Shaoxing People's Hospital, Shaoxing
Taizhou First People's Hospital, Taizhou
Henan Cancer Hospital, Zhengzhou
Sun Yat-Sen Memorial Hospital, Guangzhou
Zhujiang Hospital, Southern Medical University, Guangzhou
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou
Hainan General Hospital, Haikou
West China Hospital, Sichuan University, Chengdu
Datong Third People's Hospital, Datong
Shanxi Provincial People's Hospital, Taiyuan
Lead Sponsor
Takeda
INDUSTRY